E-cigarette use and respiratory symptoms in adults: A systematic review and meta-analysis.

Authors:
Alqahtani MM; Alenezi FK; Almeshari MA; Alanazi AM; Taleb ZB and 15 more

Journal:
Tob Induc Dis

Publication Year: 2023

DOI:
10.18332/tid/174660

PMCID:
PMC10720266

PMID:
38098748

Journal Information

Journal Title: Tob Induc Dis

Detailed journal information not available.

Publication Details

Subject Category: Substance Abuse

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported."

Evidence found in paper:

"FUNDING There was no source of funding for this research."

Evidence found in paper:

"A systematic review of the empirical literature was conducted by following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocol (Supplementary file) . We have assessed the prevalence of respiratory symptoms among three groups; these groups included exclusive e-cigarette users, dual users (both e-cigarette and traditional cigarette users), and former smokers transitioning to e-cigarettes in an attempt to quit smoking. Therefore, we conducted a meta-analysis to examine the differences in respiratory symptom incidences among these three groups. The protocol for this study was registered with PROSPERO (#CRD42020165973). METHODS: Databases searched included PubMed, CINAHL, Cochrane Library, Embase, and Scopus. We included all English-language, empirical quantitative articles that explored the prevalence of e-cigarette-related respiratory symptoms. Random-effects models were utilized in conducting the meta-analyses. The quality of identified studies was evaluated using the NIH Study Quality Assessment Tools. This study is registered with PROSPERO(#CRD42020165973)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025